Craig S Gibbs Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Craig S Gibbs.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Craig S Gibbs. Craig S Gibbs is a Director in Aridis Pharmaceuticals, Inc. ($ARDS) and a Chief Business Officer in Forty Seven, Inc. ($FTSV).

Address: C/O FORTY SEVEN, INC. 1490 O'BRIEN DRIVE, SUITE A MENLO PARK 94025 CA

Companies in which Craig S Gibbs is an Insider

Aridis Pharmaceuticals, Inc.

Trading Symbol: ARDS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Craig S Gibbs: Director
Holdings: 0 shares
Latest Transaction: Aug 14 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Forty Seven, Inc.

Trading Symbol: FTSV
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Craig S Gibbs: Chief Business Officer
Holdings: 9,124 shares
Latest Transaction: Apr 07 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Craig S Gibbs

Sentiment: All, ARDS, FTSV

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 07 2020FTSVForty Seven, Inc.Gibbs Craig SChief Business Offi ...Option ExerciseD35.7560,2352,153,4010
Apr 07 2020FTSVForty Seven, Inc.Gibbs Craig SChief Business Offi ...Option ExerciseD8.7672,902638,4390
Apr 07 2020FTSVForty Seven, Inc.Gibbs Craig SChief Business Offi ...Option ExerciseD5.2764,515339,9940
Apr 07 2020FTSVForty Seven, Inc.Gibbs Craig SChief Business Offi ...Option ExerciseD2.02112,903227,5000
Apr 07 2020FTSVForty Seven, Inc.Gibbs Craig SChief Business Offi ...SellD0.005,924005.9 K to 0 (-100.00 %)
Apr 07 2020FTSVForty Seven, Inc.Gibbs Craig SChief Business Offi ...SellD0.0047,3270047.3 K to 0 (-100.00 %)
Apr 07 2020FTSVForty Seven, Inc.Gibbs Craig SChief Business Offi ...SellD0.0047,3270047.3 K to 0 (-100.00 %)

View all Craig S Gibbs insider transactions.